Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

INVEGA TRINZA - Health Canada Drug Approval Details

Approvals/Health Canada/INVEGA TRINZA

Authorized

STANDARD

INVEGA TRINZA

Janssen Inc🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: ae471a0b16d6bb2f
Company: Janssen Inc
Type: Standard

Approval Details

Approval Id: ae471a0b16d6bb2f
Drug Approval Canada Name: INVEGA TRINZA
Product Name: INVEGA TRINZA
Status: Marketed
Status Date: 2016-07-25
Original Market Date: 2016-07-25
Din: 02455994
Drug Class: Human
Dosage Form: Suspension (Extended-Release)
Route Of Administration: Intramuscular
Schedule: Prescription
Ahfs: 28:16.08.04
Atc Original: N05AX13 PALIPERIDONE
Atc Name: n 05 ax 13
Aig Number: 0152320011
Company Name: Janssen Inc
Company Address: 19 Green Belt Drive, Toronto, Ontario, Canada, M3C 1L9
Company Detail Path: /organization/janssen-inc

Company Information

Pharmaceutical Company Name: Janssen Inc.
Name En: Janssen Inc.
Country Name: Canada
Province Name: Ontario
City Name: north york,ontario,country_ca
Address: 19 Green Belt Dr

Active Ingredients

PALIPERIDONE (PALIPERIDONE PALMITATE)

350 MG / 1.75 ML

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ae471a0b16d6bb2f

Type

Standard

Back to Health Canada Approvals